Skip to content
Screener

Shares (Diluted) at other companies

CVS Health logo
CVS HealthCVS
1.3B+1.3%
Amazon logo
AmazonAMZN
10.9B+0.9%
Doximity logo
DoximityDOCS
191.2M-5.0%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
328.1M+1.8%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
221.3M+3.0%
Cencora logo
CencoraCOR
193.9M-0.7%

Other financials

Income statement

See full
Revenue$200.4M-1.3%
Gross profit$179.4M-5.4%
Operating income$23.6M-11.9%
Net income$8.5M-33.5%
EPS (diluted)$0.02-50.0%

Balance sheet

See full
Cash & equivalents$296.1M+5.3%
Total debt$539.0M-1.6%
Total equity$647.6M+0.7%
Total assets$2.3B+77.7%

Cash flow

See full
Operating cash flow$80.8M+63.0%
CapEx$362.0K-7.2%
Free cash flow$80.5M+63.6%

Valuation

See full
Market cap$1.27B+3.8%
Enterprise value$1.51B+1.6%
P/E78.1×+42.8×
P/S1.6×+0.1×

Profitability

See full
Gross margin90.8%-2.8pp
Operating margin9.5%-1.6pp
Net margin2.1%-2.3pp
FCF margin25.1%+1.4pp

Returns & leverage

See full
Return on equity2.5%-2.8pp
Debt / equity0.8×0.0×
Current ratio1.4×-2.8×

Where this comes from

Reported directly by GoodRx Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: GoodRx Holdings, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001809519-26-000152
(in thousands, except for per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Diluted$0.02$0.04$0.03$0.06
Weighted average shares used in computing earnings per share:
Basic339,277356,623339,839367,847
Diluted348,058357,159344,676368,345
Stock-based compensation included in costs and operating expenses:
Cost of revenue$58$122$110$222
Product development and technology4,5546,3238,76211,993
Sales and marketing4,2035,9298,45211,811

Item 1. Financial Statements

FAQ

What is GoodRx Holdings, Inc.'s shares (diluted)?
GoodRx Holdings, Inc. (GDRX) reported shares (diluted) of 348.1M in Q2 2026.
How has GoodRx Holdings, Inc.'s shares (diluted) changed year-over-year?
GoodRx Holdings, Inc.'s shares (diluted) decreased by 2.5% year-over-year, from 357.2M to 348.1M.
What is the long-term trend for GoodRx Holdings, Inc.'s shares (diluted)?
Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s shares (diluted) has grown at a -3.7% compound annual growth rate (CAGR), from 1.7B to 1.4B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about GoodRx Holdings, Inc.'s shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude